Sign in
MTRYU Stock Price, Chart, Stats & News
Monterey Bio Acquisition Corporation
Save
Monterey Bio Acquisition Corporation (MTRYU) does not currently pay a dividend.
45.32M
Market cap
–
Current P/E
–
Forward P/E
MTRYU chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | -10.01% |
ROA | -5.95% |
ROE | -1.86% |
D/E | – |
Interest coverage ratio | – |
MTRYU valuation
P/E | – |
P/S | – |
P/B | 1.62x |
P/CF | -31.90x |
P/FCF | -48.11x |
P/OCF | -31.90x |
PEG | -0.25x |
EV multiple | -23.76x |
About
Monterey Bio Acquisition Corporation, founded in New York, New York, in 2020, does not currently have significant business operations. Its sole purpose is to identify and complete a business combination, such as a merger, acquisition, or stock exchange, with one or more companies in the biotechnology sector. The firm officially changed its name to Monterey Bio Acquisition Corporation in April 2021, having previously been known as Chardan FinTech Acquisition Corp.
Similar securities
Based on sector and market capitalization
Report issue